- Home
- INFU vs KYTX Comparison
INFU vs KYTX Comparison
Compare INFU & KYTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INFU
- KYTX
- Stock Information
- Founded
- INFU 2005
- KYTX 2018
- Country
- INFU United States
- KYTX United States
- Employees
- INFU N/A
- KYTX N/A
- Industry
- INFU Medical/Dental Instruments
- KYTX
- Sector
- INFU Health Care
- KYTX
- Exchange
- INFU Nasdaq
- KYTX NYSE
- Market Cap
- INFU 104.4M
- KYTX 119.7M
- IPO Year
- INFU N/A
- KYTX 2024
- Fundamental
- Price
- INFU $5.88
- KYTX $3.89
- Analyst Decision
- INFU
- KYTX Strong Buy
- Analyst Count
- INFU 0
- KYTX 5
- Target Price
- INFU N/A
- KYTX $19.00
- AVG Volume (30 Days)
- INFU 278.1K
- KYTX 651.0K
- Earning Date
- INFU 08-07-2025
- KYTX 08-11-2025
- Dividend Yield
- INFU N/A
- KYTX N/A
- EPS Growth
- INFU 3654.89
- KYTX N/A
- EPS
- INFU 0.15
- KYTX N/A
- Revenue
- INFU $137,582,000.00
- KYTX N/A
- Revenue This Year
- INFU $11.08
- KYTX N/A
- Revenue Next Year
- INFU $8.02
- KYTX N/A
- P/E Ratio
- INFU $39.38
- KYTX N/A
- Revenue Growth
- INFU 7.98
- KYTX N/A
- 52 Week Low
- INFU $4.61
- KYTX $1.78
- 52 Week High
- INFU $9.97
- KYTX $11.40
- Technical
- Relative Strength Index (RSI)
- INFU 56.42
- KYTX 54.30
- Support Level
- INFU $6.09
- KYTX $2.52
- Resistance Level
- INFU $6.40
- KYTX $3.75
- Average True Range (ATR)
- INFU 0.26
- KYTX 0.31
- MACD
- INFU -0.02
- KYTX -0.04
- Stochastic Oscillator
- INFU 65.71
- KYTX 48.87
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.
About KYTX KYVERNA THERAPEUTICS INC
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.